Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28 - PubMed (original) (raw)
Affiliations
- PMID: 1362243
Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28
A M O'Carroll et al. Mol Pharmacol. 1992 Dec.
Erratum in
- Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin: 28.
O'Carroll AM, Lolait SJ, König M, Mahan LC. O'Carroll AM, et al. Mol Pharmacol. 1993 Dec;44(6):1278. Mol Pharmacol. 1993. PMID: 8264565 No abstract available.
Abstract
Using the polymerase chain reaction technique with degenerative primers, we obtained from a rat pituitary cDNA library a cDNA fragment, rAP236, that exhibited considerable homology to known receptors that belong to the guanine nucleotide-binding protein (G protein)-coupled receptor superfamily. Oligonucleotides to this fragment were used as probes to obtain a full-length cDNA from the rat pituitary cDNA library. This clone, rAP6-26, encoded a 383-amino acid protein with seven putative transmembrane domains that are characteristic of G protein-coupled receptors. The predicted amino acid sequence of the rAP6-26 cDNA exhibits 56-66% homology to recently cloned somatostatin (SRIF) receptors. Membranes prepared from COS-7 cells transfected with the rAP6-26 cDNA showed specific binding of 125I-Tyr11-SRIF, thus identifying the cDNA clone as a novel SRIF receptor. Radioligand binding competition analysis using somatostatin-28 (SRIF-28) and a number of cyclic SRIF analogs revealed that SRIF-28 was the most potent competitor of 125I-Tyr11-SRIF binding, with a approximately 30-fold greater affinity for the receptor than that of SRIF. In addition, binding of 125I-Tyr11-SRIF was markedly reduced in the presence of Na+ ions and GTP, indicating coupling of rAP6-26 receptors to inhibitory G proteins in COS-7 membranes. In adenylyl cyclase assays, forskolin-induced cAMP accumulation was inhibited by SRIF and SRIF-28, thus confirming that the rAP6-26 cDNA encodes a functional receptor protein. By Northern blot analysis, a approximately 2.6 kilobase mRNA encoding the receptor was present in the pituitary but not in the liver, small intestine, kidney, pancreas, cerebellum, or cortex. Lack of receptor mRNA expression in the brain was confirmed by in situ hybridization histochemical studies. Thus, we report the cloning of a novel rat pituitary SRIF receptor, termed SSTR4, that has marked preferential affinity for SRIF-28 and is linked to inhibition of adenylyl cyclase.
Similar articles
- Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28.
Panetta R, Greenwood MT, Warszynska A, Demchyshyn LL, Day R, Niznik HB, Srikant CB, Patel YC. Panetta R, et al. Mol Pharmacol. 1994 Mar;45(3):417-27. Mol Pharmacol. 1994. PMID: 7908405 - Characterization of cloned somatostatin receptors SSTR4 and SSTR5.
Raynor K, O'Carroll AM, Kong H, Yasuda K, Mahan LC, Bell GI, Reisine T. Raynor K, et al. Mol Pharmacol. 1993 Aug;44(2):385-92. Mol Pharmacol. 1993. PMID: 8102785 - Characterization of cloned human somatostatin receptor SSTR5.
O'Carroll AM, Raynor K, Lolait SJ, Reisine T. O'Carroll AM, et al. Mol Pharmacol. 1994 Aug;46(2):291-8. Mol Pharmacol. 1994. PMID: 8078491 - Somatostatin receptors.
Raynor K, Reisine T. Raynor K, et al. Crit Rev Neurobiol. 1992;6(4):273-89. Crit Rev Neurobiol. 1992. PMID: 1358464 Review. - Binding properties of somatostatin receptor subtypes.
Bruns C, Raulf F, Hoyer D, Schloos J, Lübbert H, Weckbecker G. Bruns C, et al. Metabolism. 1996 Aug;45(8 Suppl 1):17-20. doi: 10.1016/s0026-0495(96)90072-4. Metabolism. 1996. PMID: 8769372 Review.
Cited by
- Paracrine crosstalk between intestinal L- and D-cells controls secretion of glucagon-like peptide-1 in mice.
Jepsen SL, Grunddal KV, Wewer Albrechtsen NJ, Engelstoft MS, Gabe MBN, Jensen EP, Ørskov C, Poulsen SS, Rosenkilde MM, Pedersen J, Gribble FM, Reimann F, Deacon CF, Schwartz TW, Christ AD, Martin RE, Holst JJ. Jepsen SL, et al. Am J Physiol Endocrinol Metab. 2019 Dec 1;317(6):E1081-E1093. doi: 10.1152/ajpendo.00239.2019. Epub 2019 Sep 10. Am J Physiol Endocrinol Metab. 2019. PMID: 31503512 Free PMC article. - Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.
Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WA, Kooij PP, Oei HY, van Hagen M, Postema PT, de Jong M, Reubi JC, et al. Krenning EP, et al. Eur J Nucl Med. 1993 Aug;20(8):716-31. doi: 10.1007/BF00181765. Eur J Nucl Med. 1993. PMID: 8404961 Review. - Immunohistochemical and cytochemical localization of the somatostatin receptor subtype sst1 in the somatostatinergic parvocellular neuronal system of the rat hypothalamus.
Helboe L, Stidsen CE, Moller M. Helboe L, et al. J Neurosci. 1998 Jul 1;18(13):4938-45. doi: 10.1523/JNEUROSCI.18-13-04938.1998. J Neurosci. 1998. PMID: 9634559 Free PMC article. - Octreotide Effect on Growth Hormone and Somatostatin Subtype 2 Receptor mRNAs of the Human Pituitary Somatotroph Adenomas.
Stefaneanu L, Kovacs K, Thapar K, Horvath E, Melmed S, Greenman Y. Stefaneanu L, et al. Endocr Pathol. 2000 Spring;11(1):41-48. doi: 10.1385/ep:11:1:41. Endocr Pathol. 2000. PMID: 12114656 - Somatostatin and somatostatin receptor physiology.
Barnett P. Barnett P. Endocrine. 2003 Apr;20(3):255-64. doi: 10.1385/ENDO:20:3:255. Endocrine. 2003. PMID: 12721505 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Molecular Biology Databases